Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks manage gains on globally quiet day

Mon, 19th Feb 2024 15:59

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

The FTSE 100 index rose by 0.22%, reaching a value of 7,728.50 points, while the FTSE 250 index saw gains of 0.13%, closing at 19,216.90 points.

On a relatively quiet global day with Wall Street closed for the Presidents' Day holiday, Currys surged amid reported takeover interest.

In currency markets, sterling was last down 0.13% on the dollar, trading at $1.2586, while it saw a drop of 0.05% against the euro to change hands at €1.1686.

"Chinese markets ended the day in positive territory with the Shanghai Composite closing at six-week highs on the first trading day after the Lunar New Year break," said IG senior market analyst Axel Rudolph.

"Positive tourism revenues data during the holidays and an unchanged one-year medium-term lending facility rate propped up Chinese equities and led to gains in the region at large.

"The FTSE 100 has begun this week where it left off last week by outperforming its European peers during an extremely quiet session as US stock markets were closed for Presidents' Day."

Rudolph added that oil prices had risen amid the quiet trading, as European natural gas futures fell to an eight-month low.

"The gold price appreciated slightly despite the dollar regaining some of its recently lost ground in low volume and low volatility trading ahead of Wednesday's FOMC minutes."

Housing market shows resilience in February

In economic news, the housing market showed resilience in February, bolstered by a continuation of declining mortgage rates, according to fresh industry data.

Rightmove's latest house price index showed a notable uptick, with average new seller prices increasing 0.9% compared to the prior month, and by 0.1% year-on-year.

That marks the first time in six months that the annual price change had entered positive territory.

In January, house prices experienced a month-on-month increase of 1.3%, although they recorded a year-on-year decline of 0.7%.

The average asking price for homes now stood at £362,839.

Additionally, agreed sales during the initial six weeks of 2024 surged 16% compared to the same period a year earlier.

Furthermore, there were notable increases in both new listings and buyer enquiries, which rose by 7% each year-on-year.

"Early-bird Boxing Day buyers got a head start in cherry-picking from a record level of new property choice and have now been joined by many other buyers also believing that 2024 offers the right market conditions to move," said Tim Bannister, director of property science at Rightmove.

"Mortgage rates have fallen considerably from their peak and are now remaining broadly stable after the uncertainty of late 2022 and 2023.

"Momentum to move in 2024 is continuing to build."

Currys surges on takeover talk, Moneysupermarket in the red

On London's equity markets, Currys rocketed 36.36% after confirmations from US private equity firm Elliott Advisors and Chinese e-commerce giant JD.com, both considering separate bids for the struggling British electrical retailer.

Currys said it had rejected a £700m proposal from Elliott, citing undervaluation of the chain and its future prospects.

Elsewhere, Rolls-Royce Holdings gained 2.68% ahead of its full-year results scheduled for Thursday.

AstraZeneca rallied 2.62% following approval from the US Food and Drug Administration (FDA) for a combination of its cancer drug Tagrisso with chemotherapy to treat a type of lung cancer.

SSE and Bank of Georgia Group recorded more modest gains, with SSE benefiting from an upgrade to 'buy' at Jefferies, and Bank of Georgia rising after agreeing to acquire Armenian bank Ameriabank for $303.6m.

On the downside, Moneysupermarket Group declined 1.7%, despite reporting record full-year revenues driven by its insurance business's strong performance.

Anglo American also faced a downturn, dropping 1.37%, after it announced a restructuring in its platinum arm, potentially affecting over 4,300 jobs due to lower prices and higher costs amid a global economic slowdown.

Flutter Entertainment closed in the red, losing 1.29%, despite Berenberg raising its price target on the shares and reiterating its 'buy' recommendation.

Berenberg emphasised Flutter's strong growth and balance sheet flexibility, highlighting it as their "top pick" in the leisure space for the 2024 financial year, particularly noting its promising performance in the lucrative US market.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,728.50 0.22%

FTSE 250 (MCX) 19,216.90 0.13%

techMARK (TASX) 4,399.69 0.39%

FTSE 100 - Risers

Rolls-Royce Holdings (RR.) 334.20p 3.37%

AstraZeneca (AZN) 10,418.00p 3.21%

Vodafone Group (VOD) 67.10p 2.24%

SEGRO (SGRO) 866.20p 1.98%

InterContinental Hotels Group (IHG) 7,902.00p 1.83%

Barclays (BARC) 149.00p 1.55%

Smith & Nephew (SN.) 1,132.50p 1.39%

Melrose Industries (MRO) 618.60p 1.28%

Frasers Group (FRAS) 839.50p 1.21%

Intertek Group (ITRK) 4,479.00p 1.11%

FTSE 100 - Fallers

Centrica (CNA) 130.80p -5.97%

Beazley (BEZ) 570.00p -2.56%

Kingfisher (KGF) 222.60p -2.20%

NATWEST GROUP (NWG) 224.60p -2.14%

Fresnillo (FRES) 477.50p -2.05%

British American Tobacco (BATS) 2,369.50p -1.82%

Scottish Mortgage Inv Trust (SMT) 795.20p -1.61%

Prudential (PRU) 821.20p -1.58%

Rio Tinto (RIO) 5,428.00p -1.58%

Burberry Group (BRBY) 1,319.50p -1.42%

FTSE 250 - Risers

Currys (CURY) 64.20p 36.36%

Bank of Georgia Group (BGEO) 4,225.00p 6.56%

W.A.G Payment Solutions (WPS) 88.00p 5.77%

Renishaw (RSW) 4,240.00p 2.91%

Capital Gearing Trust (CGT) 4,655.00p 2.65%

Watches of Switzerland Group (WOSG) 434.60p 2.60%

Me Group International (MEGP) 135.20p 2.58%

Mobico Group (MCG) 84.80p 2.29%

Senior (SNR) 161.40p 2.28%

Auction Technology Group (ATG) 610.00p 2.18%

FTSE 250 - Fallers

Indivior (INDV) 1,347.00p -4.06%

Direct Line Insurance Group (DLG) 166.10p -2.87%

Baltic Classifieds Group (BCG) 231.00p -2.74%

FDM Group (Holdings) (FDM) 415.50p -2.35%

Aston Martin Lagonda Global Holdings (AML) 165.70p -2.30%

Abrdn (ABDN) 160.65p -2.22%

Elementis (ELM) 137.00p -2.14%

Moneysupermarket.com Group (MONY) 246.60p -1.83%

Hochschild Mining (HOC) 89.35p -1.71%

Monks Inv Trust (MNKS) 1,084.00p -1.63%

More News
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.